Loading...
Please support adult stem cell research
CSBQ
CSBQ
Authors
Contributor(s)
Keywords
Files
Research Projects
Organizational Units
Journal Issue
Online Access
Abstract
"As a physician of 30 years experience I have been following the stem cell debate with interest. The facts I read in the scientific journals give a different picture to what has appeared in the general media. The public has been kept poorly informed by a carefully orchestrated campaign by the IVF embryo industry. The embryo researchers speak only of embryonic sources of stem cells. In fact embryonic stem cells have immune and chemical disadvantages, and are likely to be used only for drug research and toxicology studies. No doubt Big Biotech will make big money in those areas, but embryonic stem cells have achieved nothing to justify the hype about miracle cures. Nobel Prize winner Sir Gustav Nossal suggests that another 10 years study would be needed to make embryonic stem cell therapy both workable and safe."
Note(s)
Topic
Type
Preprint
Date
2002-05-30
Identifier
ISBN
DOI
Copyright/License
With permission of the license/copyright holder